临床试验/IRCT20110523006565N2

IRCT20110523006565N2尚未招募未知

Bioequivalence Study of Ursodeoxycholic acid Tablets manufactured by Raihaneh and So-Se-Pharm Pharmaceutical companies

Kermanshah University of Medical Sciences0 个研究点目标入组 24 人开始时间: 待定最近更新: 2022年2月7日

适应症

试验速览

阶段: 未知
状态: 尚未招募
发起方: Kermanshah University of Medical Sciences
入组人数: 24

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 18 years 至 45 years（—）
性别: All

入选标准

•Written informed consent.
•Normal findings in the physical examination.
•Clinical laboratory values within 10% above or below the laboratory’s stated normal range
•To be a non-smoker

排除标准

•History of hypersensitivity to the study drug or related products
•Significant history or presence of gastrointestinal, liver or kidney disease, or any other condition known to interfere with the absorption, distribution, metabolism or excretion of common medications
•Any clinically significant illness during the 4 weeks prior to day 1 of this study
•Maintenance therapy with any drug, or history of drug dependence, alcohol abuse, or serious neurological or psychological disease
•Use of any systemic medication (including OTC preparations) within 14 days preceding day 1 of this study
•HIV and Hepatitis A, B and C positive subjects

研究者

发起方

Kermanshah University of Medical Sciences

相似试验

Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..

IRCT20210519051345N64Tabriz University of Medical Sciences24

Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..

IRCT20210519051345N16Tabriz University of Medical Sciences24

Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg tabletIn the present study, the products will be administered to healthy volunteers..

IRCT20210519051345N30Tabriz University of Medical Sciences24

Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsule

IRCT20210519051345N25Tabriz University of Medical Sciences24

Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..

IRCT20210519051345N47Tabriz University of Medical Sciences24